nodes	percent_of_prediction	percent_of_DWPC	metapath
Indomethacin—PPARA—metabolic syndrome X	0.37	0.537	CbGaD
Indomethacin—PPARG—metabolic syndrome X	0.177	0.257	CbGaD
Indomethacin—PTGS2—metabolic syndrome X	0.0748	0.109	CbGaD
Indomethacin—ALB—metabolic syndrome X	0.0666	0.0968	CbGaD
Indomethacin—Abdominal distress—Metformin—metabolic syndrome X	0.0113	0.178	CcSEcCtD
Indomethacin—PPARA—brown adipose tissue—metabolic syndrome X	0.0073	0.0945	CbGeAlD
Indomethacin—Distention—Metformin—metabolic syndrome X	0.00648	0.102	CcSEcCtD
Indomethacin—PPARG—brown adipose tissue—metabolic syndrome X	0.00401	0.052	CbGeAlD
Indomethacin—Emotional distress—Metformin—metabolic syndrome X	0.00359	0.0566	CcSEcCtD
Indomethacin—Abdominal bloating—Metformin—metabolic syndrome X	0.00321	0.0505	CcSEcCtD
Indomethacin—Azotaemia—Metformin—metabolic syndrome X	0.00286	0.0452	CcSEcCtD
Indomethacin—Acidosis—Metformin—metabolic syndrome X	0.00276	0.0435	CcSEcCtD
Indomethacin—PPARA—blood vessel—metabolic syndrome X	0.0025	0.0324	CbGeAlD
Indomethacin—Respiratory distress—Metformin—metabolic syndrome X	0.0024	0.0379	CcSEcCtD
Indomethacin—Heartburn—Metformin—metabolic syndrome X	0.00222	0.035	CcSEcCtD
Indomethacin—PTGR2—cardiovascular system—metabolic syndrome X	0.00208	0.027	CbGeAlD
Indomethacin—PTGR2—kidney—metabolic syndrome X	0.00204	0.0264	CbGeAlD
Indomethacin—Agomelatine—MTNR1B—metabolic syndrome X	0.00191	0.266	CrCbGaD
Indomethacin—PTGR2—adipose tissue—metabolic syndrome X	0.00184	0.0238	CbGeAlD
Indomethacin—PPARG—artery—metabolic syndrome X	0.00177	0.0229	CbGeAlD
Indomethacin—Fenofibrate—PPARA—metabolic syndrome X	0.00173	0.242	CrCbGaD
Indomethacin—PPARG—endothelium—metabolic syndrome X	0.00149	0.0193	CbGeAlD
Indomethacin—PPARG—blood vessel—metabolic syndrome X	0.00138	0.0178	CbGeAlD
Indomethacin—Lightheadedness—Metformin—metabolic syndrome X	0.00137	0.0215	CcSEcCtD
Indomethacin—PTGR2—liver—metabolic syndrome X	0.00129	0.0167	CbGeAlD
Indomethacin—GLO1—cardiovascular system—metabolic syndrome X	0.00129	0.0167	CbGeAlD
Indomethacin—ABCC11—liver—metabolic syndrome X	0.00127	0.0165	CbGeAlD
Indomethacin—GLO1—kidney—metabolic syndrome X	0.00126	0.0163	CbGeAlD
Indomethacin—UGT1A9—kidney—metabolic syndrome X	0.00122	0.0158	CbGeAlD
Indomethacin—PLA2G2A—cardiovascular system—metabolic syndrome X	0.0012	0.0155	CbGeAlD
Indomethacin—ABCC6—cardiovascular system—metabolic syndrome X	0.00118	0.0153	CbGeAlD
Indomethacin—PLA2G2A—kidney—metabolic syndrome X	0.00117	0.0152	CbGeAlD
Indomethacin—Renal impairment—Metformin—metabolic syndrome X	0.00116	0.0184	CcSEcCtD
Indomethacin—ABCC6—kidney—metabolic syndrome X	0.00116	0.015	CbGeAlD
Indomethacin—Hypoglycaemia—Metformin—metabolic syndrome X	0.00114	0.0179	CcSEcCtD
Indomethacin—GLO1—adipose tissue—metabolic syndrome X	0.00113	0.0147	CbGeAlD
Indomethacin—PPARA—cardiovascular system—metabolic syndrome X	0.00112	0.0145	CbGeAlD
Indomethacin—PPARA—kidney—metabolic syndrome X	0.00109	0.0142	CbGeAlD
Indomethacin—PLA2G2A—adipose tissue—metabolic syndrome X	0.00105	0.0137	CbGeAlD
Indomethacin—SLC10A1—kidney—metabolic syndrome X	0.00105	0.0136	CbGeAlD
Indomethacin—CXCL8—adipose tissue—metabolic syndrome X	0.00104	0.0135	CbGeAlD
Indomethacin—ABCC6—adipose tissue—metabolic syndrome X	0.00104	0.0135	CbGeAlD
Indomethacin—Abdominal pain upper—Metformin—metabolic syndrome X	0.00101	0.016	CcSEcCtD
Indomethacin—PPARA—adipose tissue—metabolic syndrome X	0.000985	0.0128	CbGeAlD
Indomethacin—UGT2B7—kidney—metabolic syndrome X	0.000985	0.0128	CbGeAlD
Indomethacin—Abdominal distension—Metformin—metabolic syndrome X	0.000964	0.0152	CcSEcCtD
Indomethacin—SLC22A11—kidney—metabolic syndrome X	0.00096	0.0124	CbGeAlD
Indomethacin—PTGS1—artery—metabolic syndrome X	0.000945	0.0122	CbGeAlD
Indomethacin—SLC22A7—kidney—metabolic syndrome X	0.000937	0.0121	CbGeAlD
Indomethacin—Abdominal discomfort—Metformin—metabolic syndrome X	0.000918	0.0145	CcSEcCtD
Indomethacin—PTGS2—artery—metabolic syndrome X	0.000903	0.0117	CbGeAlD
Indomethacin—Bezafibrate—HMGCR—metabolic syndrome X	0.000891	0.124	CrCbGaD
Indomethacin—Bezafibrate—PPARA—metabolic syndrome X	0.000877	0.122	CrCbGaD
Indomethacin—Drowsiness—Metformin—metabolic syndrome X	0.000854	0.0135	CcSEcCtD
Indomethacin—UGT1A1—kidney—metabolic syndrome X	0.000838	0.0108	CbGeAlD
Indomethacin—Neuropathy peripheral—Metformin—metabolic syndrome X	0.000837	0.0132	CcSEcCtD
Indomethacin—CES1—cardiovascular system—metabolic syndrome X	0.000829	0.0107	CbGeAlD
Indomethacin—AKR1C3—adipose tissue—metabolic syndrome X	0.000819	0.0106	CbGeAlD
Indomethacin—PTGS1—endothelium—metabolic syndrome X	0.000798	0.0103	CbGeAlD
Indomethacin—GLO1—liver—metabolic syndrome X	0.000796	0.0103	CbGeAlD
Indomethacin—Bradycardia—Metformin—metabolic syndrome X	0.00078	0.0123	CcSEcCtD
Indomethacin—UGT1A9—liver—metabolic syndrome X	0.000772	0.01	CbGeAlD
Indomethacin—Hepatitis—Metformin—metabolic syndrome X	0.000766	0.0121	CcSEcCtD
Indomethacin—PTGS2—endothelium—metabolic syndrome X	0.000763	0.00988	CbGeAlD
Indomethacin—PLA2G2A—liver—metabolic syndrome X	0.00074	0.00958	CbGeAlD
Indomethacin—PTGS1—blood vessel—metabolic syndrome X	0.000736	0.00953	CbGeAlD
Indomethacin—CXCL8—liver—metabolic syndrome X	0.000732	0.00948	CbGeAlD
Indomethacin—ABCC6—liver—metabolic syndrome X	0.000732	0.00948	CbGeAlD
Indomethacin—CES1—adipose tissue—metabolic syndrome X	0.000731	0.00947	CbGeAlD
Indomethacin—Flushing—Metformin—metabolic syndrome X	0.000711	0.0112	CcSEcCtD
Indomethacin—PTGS2—blood vessel—metabolic syndrome X	0.000704	0.00911	CbGeAlD
Indomethacin—SLCO1B1—kidney—metabolic syndrome X	0.000697	0.00902	CbGeAlD
Indomethacin—PPARA—liver—metabolic syndrome X	0.000691	0.00895	CbGeAlD
Indomethacin—Erythema—Metformin—metabolic syndrome X	0.000667	0.0105	CcSEcCtD
Indomethacin—SLC10A1—liver—metabolic syndrome X	0.000664	0.0086	CbGeAlD
Indomethacin—ABCC3—kidney—metabolic syndrome X	0.000661	0.00856	CbGeAlD
Indomethacin—Flatulence—Metformin—metabolic syndrome X	0.000657	0.0104	CcSEcCtD
Indomethacin—Vision blurred—Metformin—metabolic syndrome X	0.000629	0.00991	CcSEcCtD
Indomethacin—UGT2B7—liver—metabolic syndrome X	0.000623	0.00806	CbGeAlD
Indomethacin—Ill-defined disorder—Metformin—metabolic syndrome X	0.000619	0.00976	CcSEcCtD
Indomethacin—PPARG—cardiovascular system—metabolic syndrome X	0.000614	0.00796	CbGeAlD
Indomethacin—SLC22A11—liver—metabolic syndrome X	0.000607	0.00786	CbGeAlD
Indomethacin—Malaise—Metformin—metabolic syndrome X	0.000602	0.00949	CcSEcCtD
Indomethacin—PPARG—kidney—metabolic syndrome X	0.000601	0.00778	CbGeAlD
Indomethacin—Syncope—Metformin—metabolic syndrome X	0.000598	0.00943	CcSEcCtD
Indomethacin—ABCC3—adipose tissue—metabolic syndrome X	0.000596	0.00772	CbGeAlD
Indomethacin—SLC22A7—liver—metabolic syndrome X	0.000592	0.00767	CbGeAlD
Indomethacin—Palpitations—Metformin—metabolic syndrome X	0.00059	0.0093	CcSEcCtD
Indomethacin—Loss of consciousness—Metformin—metabolic syndrome X	0.000586	0.00924	CcSEcCtD
Indomethacin—Hypertension—Metformin—metabolic syndrome X	0.000576	0.00908	CcSEcCtD
Indomethacin—AKR1C3—liver—metabolic syndrome X	0.000574	0.00743	CbGeAlD
Indomethacin—Chest pain—Metformin—metabolic syndrome X	0.000568	0.00895	CcSEcCtD
Indomethacin—SLCO1A2—kidney—metabolic syndrome X	0.000567	0.00734	CbGeAlD
Indomethacin—Discomfort—Metformin—metabolic syndrome X	0.000561	0.00885	CcSEcCtD
Indomethacin—ABCC4—kidney—metabolic syndrome X	0.000546	0.00707	CbGeAlD
Indomethacin—Oedema—Metformin—metabolic syndrome X	0.000544	0.00858	CcSEcCtD
Indomethacin—PPARG—adipose tissue—metabolic syndrome X	0.000542	0.00701	CbGeAlD
Indomethacin—SLC22A8—kidney—metabolic syndrome X	0.000542	0.00701	CbGeAlD
Indomethacin—Shock—Metformin—metabolic syndrome X	0.000536	0.00845	CcSEcCtD
Indomethacin—Thrombocytopenia—Metformin—metabolic syndrome X	0.000533	0.00841	CcSEcCtD
Indomethacin—UGT1A1—liver—metabolic syndrome X	0.000529	0.00685	CbGeAlD
Indomethacin—ABCC2—kidney—metabolic syndrome X	0.000528	0.00684	CbGeAlD
Indomethacin—Hyperhidrosis—Metformin—metabolic syndrome X	0.000526	0.0083	CcSEcCtD
Indomethacin—Anorexia—Metformin—metabolic syndrome X	0.000519	0.00818	CcSEcCtD
Indomethacin—CES1—liver—metabolic syndrome X	0.000513	0.00664	CbGeAlD
Indomethacin—Hypotension—Metformin—metabolic syndrome X	0.000509	0.00802	CcSEcCtD
Indomethacin—ABCC4—adipose tissue—metabolic syndrome X	0.000492	0.00637	CbGeAlD
Indomethacin—Paraesthesia—Metformin—metabolic syndrome X	0.000489	0.00771	CcSEcCtD
Indomethacin—Agomelatine—HTR2C—metabolic syndrome X	0.000487	0.068	CrCbGaD
Indomethacin—Dyspnoea—Metformin—metabolic syndrome X	0.000485	0.00765	CcSEcCtD
Indomethacin—Somnolence—Metformin—metabolic syndrome X	0.000484	0.00763	CcSEcCtD
Indomethacin—Dyspepsia—Metformin—metabolic syndrome X	0.000479	0.00756	CcSEcCtD
Indomethacin—Decreased appetite—Metformin—metabolic syndrome X	0.000473	0.00746	CcSEcCtD
Indomethacin—Fatigue—Metformin—metabolic syndrome X	0.000469	0.0074	CcSEcCtD
Indomethacin—Constipation—Metformin—metabolic syndrome X	0.000466	0.00734	CcSEcCtD
Indomethacin—Feeling abnormal—Metformin—metabolic syndrome X	0.000449	0.00707	CcSEcCtD
Indomethacin—Gastrointestinal pain—Metformin—metabolic syndrome X	0.000445	0.00702	CcSEcCtD
Indomethacin—SLCO1B1—liver—metabolic syndrome X	0.00044	0.0057	CbGeAlD
Indomethacin—ABCB1—blood vessel—metabolic syndrome X	0.000435	0.00564	CbGeAlD
Indomethacin—Urticaria—Metformin—metabolic syndrome X	0.000433	0.00682	CcSEcCtD
Indomethacin—Abdominal pain—Metformin—metabolic syndrome X	0.00043	0.00679	CcSEcCtD
Indomethacin—Bezafibrate—PPARG—metabolic syndrome X	0.00042	0.0586	CrCbGaD
Indomethacin—ABCC1—adipose tissue—metabolic syndrome X	0.000419	0.00543	CbGeAlD
Indomethacin—ABCC3—liver—metabolic syndrome X	0.000418	0.00541	CbGeAlD
Indomethacin—Asthenia—Metformin—metabolic syndrome X	0.000391	0.00616	CcSEcCtD
Indomethacin—Pruritus—Metformin—metabolic syndrome X	0.000385	0.00607	CcSEcCtD
Indomethacin—PPARG—liver—metabolic syndrome X	0.00038	0.00492	CbGeAlD
Indomethacin—Diarrhoea—Metformin—metabolic syndrome X	0.000373	0.00587	CcSEcCtD
Indomethacin—Dizziness—Metformin—metabolic syndrome X	0.00036	0.00568	CcSEcCtD
Indomethacin—CYP2C9—cardiovascular system—metabolic syndrome X	0.00036	0.00466	CbGeAlD
Indomethacin—SLCO1A2—liver—metabolic syndrome X	0.000358	0.00464	CbGeAlD
Indomethacin—ALB—liver—metabolic syndrome X	0.000356	0.00461	CbGeAlD
Indomethacin—Vomiting—Metformin—metabolic syndrome X	0.000346	0.00546	CcSEcCtD
Indomethacin—ABCC4—liver—metabolic syndrome X	0.000345	0.00447	CbGeAlD
Indomethacin—Rash—Metformin—metabolic syndrome X	0.000343	0.00541	CcSEcCtD
Indomethacin—Dermatitis—Metformin—metabolic syndrome X	0.000343	0.00541	CcSEcCtD
Indomethacin—Headache—Metformin—metabolic syndrome X	0.000341	0.00538	CcSEcCtD
Indomethacin—ABCC2—liver—metabolic syndrome X	0.000334	0.00432	CbGeAlD
Indomethacin—PTGS1—cardiovascular system—metabolic syndrome X	0.000328	0.00425	CbGeAlD
Indomethacin—Nausea—Metformin—metabolic syndrome X	0.000323	0.0051	CcSEcCtD
Indomethacin—PTGS1—kidney—metabolic syndrome X	0.000321	0.00416	CbGeAlD
Indomethacin—Bromfenac—PTGS2—metabolic syndrome X	0.000321	0.0448	CrCbGaD
Indomethacin—PTGS2—cardiovascular system—metabolic syndrome X	0.000314	0.00406	CbGeAlD
Indomethacin—PTGS2—kidney—metabolic syndrome X	0.000307	0.00398	CbGeAlD
Indomethacin—ABCC1—liver—metabolic syndrome X	0.000294	0.00381	CbGeAlD
Indomethacin—PTGS1—adipose tissue—metabolic syndrome X	0.00029	0.00375	CbGeAlD
Indomethacin—CYP2C19—liver—metabolic syndrome X	0.000287	0.00372	CbGeAlD
Indomethacin—PTGS2—adipose tissue—metabolic syndrome X	0.000277	0.00358	CbGeAlD
Indomethacin—CYP2C9—liver—metabolic syndrome X	0.000222	0.00288	CbGeAlD
Indomethacin—Tolmetin—PTGS2—metabolic syndrome X	0.000216	0.0301	CrCbGaD
Indomethacin—ABCB1—cardiovascular system—metabolic syndrome X	0.000194	0.00251	CbGeAlD
Indomethacin—PTGS2—liver—metabolic syndrome X	0.000194	0.00251	CbGeAlD
Indomethacin—ABCB1—kidney—metabolic syndrome X	0.00019	0.00246	CbGeAlD
Indomethacin—ABCB1—adipose tissue—metabolic syndrome X	0.000171	0.00222	CbGeAlD
Indomethacin—Naproxen—PTGS2—metabolic syndrome X	0.000162	0.0226	CrCbGaD
Indomethacin—Naproxen—ALB—metabolic syndrome X	0.000144	0.0202	CrCbGaD
Indomethacin—ABCB1—liver—metabolic syndrome X	0.00012	0.00155	CbGeAlD
Indomethacin—ALB—Metabolism—APOC3—metabolic syndrome X	6.16e-06	3.75e-05	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism—PPARA—metabolic syndrome X	6.15e-06	3.75e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—metabolic syndrome X	6.14e-06	3.74e-05	CbGpPWpGaD
Indomethacin—ALB—Hemostasis—SERPINE1—metabolic syndrome X	6.14e-06	3.74e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—APOA5—metabolic syndrome X	6.12e-06	3.73e-05	CbGpPWpGaD
Indomethacin—PPARG—Developmental Biology—AKT1—metabolic syndrome X	6.1e-06	3.72e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—TRIB3—metabolic syndrome X	6.09e-06	3.71e-05	CbGpPWpGaD
Indomethacin—UGT1A1—Metabolism—APOE—metabolic syndrome X	6.06e-06	3.69e-05	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism—APOE—metabolic syndrome X	6.06e-06	3.69e-05	CbGpPWpGaD
Indomethacin—PPARG—Metabolism—INS—metabolic syndrome X	6.02e-06	3.67e-05	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—PLA2G4A—metabolic syndrome X	6e-06	3.66e-05	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism—APOA1—metabolic syndrome X	5.99e-06	3.65e-05	CbGpPWpGaD
Indomethacin—UGT1A1—Metabolism—APOA1—metabolic syndrome X	5.99e-06	3.65e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—CETP—metabolic syndrome X	5.98e-06	3.64e-05	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism—AGT—metabolic syndrome X	5.96e-06	3.63e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—SLC2A4—metabolic syndrome X	5.96e-06	3.63e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—ABCA1—metabolic syndrome X	5.96e-06	3.63e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—INS—metabolic syndrome X	5.96e-06	3.63e-05	CbGpPWpGaD
Indomethacin—ABCC4—Hemostasis—AKT1—metabolic syndrome X	5.95e-06	3.63e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism of lipids and lipoproteins—AGT—metabolic syndrome X	5.95e-06	3.62e-05	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—LPL—metabolic syndrome X	5.89e-06	3.59e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—SERPINE1—metabolic syndrome X	5.87e-06	3.58e-05	CbGpPWpGaD
Indomethacin—ABCB1—Transmembrane transport of small molecules—APOA1—metabolic syndrome X	5.86e-06	3.57e-05	CbGpPWpGaD
Indomethacin—ALB—Hemostasis—NOS3—metabolic syndrome X	5.86e-06	3.57e-05	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—PPARA—metabolic syndrome X	5.85e-06	3.56e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—APOB—metabolic syndrome X	5.85e-06	3.56e-05	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism—APOE—metabolic syndrome X	5.84e-06	3.56e-05	CbGpPWpGaD
Indomethacin—UGT2B7—Metabolism—ALB—metabolic syndrome X	5.84e-06	3.56e-05	CbGpPWpGaD
Indomethacin—ABCC3—Metabolism—ALB—metabolic syndrome X	5.84e-06	3.56e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism of lipids and lipoproteins—APOE—metabolic syndrome X	5.83e-06	3.55e-05	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism—APOA1—metabolic syndrome X	5.77e-06	3.52e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—GOT1—metabolic syndrome X	5.77e-06	3.52e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—GGT1—metabolic syndrome X	5.77e-06	3.52e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—metabolic syndrome X	5.76e-06	3.51e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—SCARB1—metabolic syndrome X	5.73e-06	3.49e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—TRIB3—metabolic syndrome X	5.69e-06	3.47e-05	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—AGT—metabolic syndrome X	5.66e-06	3.45e-05	CbGpPWpGaD
Indomethacin—SLCO1A2—Metabolism—PPARG—metabolic syndrome X	5.65e-06	3.44e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—NOS3—metabolic syndrome X	5.61e-06	3.42e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—NAMPT—metabolic syndrome X	5.6e-06	3.41e-05	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—CD36—metabolic syndrome X	5.6e-06	3.41e-05	CbGpPWpGaD
Indomethacin—UGT2B7—Metabolism—NOS3—metabolic syndrome X	5.58e-06	3.4e-05	CbGpPWpGaD
Indomethacin—ABCC3—Metabolism—NOS3—metabolic syndrome X	5.58e-06	3.4e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—LPL—metabolic syndrome X	5.58e-06	3.4e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—metabolic syndrome X	5.57e-06	3.39e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—LIPC—metabolic syndrome X	5.57e-06	3.39e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—GCK—metabolic syndrome X	5.57e-06	3.39e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—SREBF1—metabolic syndrome X	5.56e-06	3.39e-05	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—APOE—metabolic syndrome X	5.55e-06	3.38e-05	CbGpPWpGaD
Indomethacin—SLCO1A2—Metabolism—INS—metabolic syndrome X	5.54e-06	3.38e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—APOC3—metabolic syndrome X	5.53e-06	3.37e-05	CbGpPWpGaD
Indomethacin—PPARG—Metabolism—ALB—metabolic syndrome X	5.52e-06	3.36e-05	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—APOA1—metabolic syndrome X	5.49e-06	3.34e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—SERPINE1—metabolic syndrome X	5.47e-06	3.33e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—NAMPT—metabolic syndrome X	5.47e-06	3.33e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—LIPC—metabolic syndrome X	5.43e-06	3.31e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—GCK—metabolic syndrome X	5.43e-06	3.31e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—GOT2—metabolic syndrome X	5.41e-06	3.3e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—HMGCR—metabolic syndrome X	5.41e-06	3.3e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—APOC3—metabolic syndrome X	5.4e-06	3.29e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—CETP—metabolic syndrome X	5.37e-06	3.27e-05	CbGpPWpGaD
Indomethacin—PLA2G2A—Metabolism—AKT1—metabolic syndrome X	5.34e-06	3.26e-05	CbGpPWpGaD
Indomethacin—PPARG—Metabolism—NOS3—metabolic syndrome X	5.28e-06	3.22e-05	CbGpPWpGaD
Indomethacin—UGT1A1—Metabolism—PPARG—metabolic syndrome X	5.28e-06	3.21e-05	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism—PPARG—metabolic syndrome X	5.28e-06	3.21e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—CETP—metabolic syndrome X	5.24e-06	3.19e-05	CbGpPWpGaD
Indomethacin—ALB—Platelet activation, signaling and aggregation—AKT1—metabolic syndrome X	5.23e-06	3.18e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—NOS3—metabolic syndrome X	5.22e-06	3.18e-05	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—PPARA—metabolic syndrome X	5.2e-06	3.17e-05	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism—INS—metabolic syndrome X	5.17e-06	3.15e-05	CbGpPWpGaD
Indomethacin—UGT1A1—Metabolism—INS—metabolic syndrome X	5.17e-06	3.15e-05	CbGpPWpGaD
Indomethacin—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—metabolic syndrome X	5.15e-06	3.14e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—SCARB1—metabolic syndrome X	5.14e-06	3.13e-05	CbGpPWpGaD
Indomethacin—UGT2B7—Metabolism—PTGS2—metabolic syndrome X	5.11e-06	3.11e-05	CbGpPWpGaD
Indomethacin—ABCC3—Metabolism—PTGS2—metabolic syndrome X	5.11e-06	3.11e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—NAMPT—metabolic syndrome X	5.11e-06	3.11e-05	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism—PPARG—metabolic syndrome X	5.09e-06	3.1e-05	CbGpPWpGaD
Indomethacin—SLCO1A2—Metabolism—ALB—metabolic syndrome X	5.08e-06	3.1e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—metabolic syndrome X	5.08e-06	3.09e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—LIPC—metabolic syndrome X	5.07e-06	3.09e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—GCK—metabolic syndrome X	5.07e-06	3.09e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Disease—IL6—metabolic syndrome X	5.06e-06	3.08e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—APOC3—metabolic syndrome X	5.04e-06	3.07e-05	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—AGT—metabolic syndrome X	5.04e-06	3.07e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—SCARB1—metabolic syndrome X	5.02e-06	3.06e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism of lipids and lipoproteins—ALB—metabolic syndrome X	5.01e-06	3.05e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—SREBF1—metabolic syndrome X	4.99e-06	3.04e-05	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism—INS—metabolic syndrome X	4.99e-06	3.04e-05	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—APOE—metabolic syndrome X	4.94e-06	3.01e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—APOB—metabolic syndrome X	4.9e-06	2.98e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—CETP—metabolic syndrome X	4.9e-06	2.98e-05	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—APOA1—metabolic syndrome X	4.88e-06	2.97e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism of lipids and lipoproteins—PTGS2—metabolic syndrome X	4.88e-06	2.97e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—SREBF1—metabolic syndrome X	4.87e-06	2.97e-05	CbGpPWpGaD
Indomethacin—SLCO1A2—Metabolism—NOS3—metabolic syndrome X	4.86e-06	2.96e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—GOT2—metabolic syndrome X	4.86e-06	2.96e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—HMGCR—metabolic syndrome X	4.86e-06	2.96e-05	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—PPARG—metabolic syndrome X	4.83e-06	2.95e-05	CbGpPWpGaD
Indomethacin—PPARG—Metabolism—PTGS2—metabolic syndrome X	4.83e-06	2.94e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—ABCA1—metabolic syndrome X	4.82e-06	2.94e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—SLC2A4—metabolic syndrome X	4.82e-06	2.94e-05	CbGpPWpGaD
Indomethacin—CXCL8—GPCR downstream signaling—AKT1—metabolic syndrome X	4.8e-06	2.93e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—PTGS2—metabolic syndrome X	4.78e-06	2.91e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—PLA2G4A—metabolic syndrome X	4.76e-06	2.9e-05	CbGpPWpGaD
Indomethacin—UGT1A1—Metabolism—ALB—metabolic syndrome X	4.74e-06	2.89e-05	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism—ALB—metabolic syndrome X	4.74e-06	2.89e-05	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—INS—metabolic syndrome X	4.74e-06	2.89e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—HMGCR—metabolic syndrome X	4.74e-06	2.89e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—GOT2—metabolic syndrome X	4.74e-06	2.89e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling by GPCR—IL6—metabolic syndrome X	4.73e-06	2.88e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—TGFB1—metabolic syndrome X	4.7e-06	2.86e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—SCARB1—metabolic syndrome X	4.69e-06	2.86e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—APOE—metabolic syndrome X	4.68e-06	2.85e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—LPL—metabolic syndrome X	4.68e-06	2.85e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—GGT1—metabolic syndrome X	4.67e-06	2.85e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—GOT1—metabolic syndrome X	4.67e-06	2.85e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Disease—AKT1—metabolic syndrome X	4.66e-06	2.84e-05	CbGpPWpGaD
Indomethacin—ABCB1—Transmembrane transport of small molecules—ALB—metabolic syndrome X	4.65e-06	2.83e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—APOA1—metabolic syndrome X	4.63e-06	2.82e-05	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism—ALB—metabolic syndrome X	4.57e-06	2.79e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism of lipids and lipoproteins—ALB—metabolic syndrome X	4.56e-06	2.78e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—SREBF1—metabolic syndrome X	4.55e-06	2.77e-05	CbGpPWpGaD
Indomethacin—SLC10A1—Metabolism—AKT1—metabolic syndrome X	4.54e-06	2.77e-05	CbGpPWpGaD
Indomethacin—UGT1A1—Metabolism—NOS3—metabolic syndrome X	4.54e-06	2.77e-05	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism—NOS3—metabolic syndrome X	4.54e-06	2.77e-05	CbGpPWpGaD
Indomethacin—SLCO1A2—Metabolism—PTGS2—metabolic syndrome X	4.45e-06	2.71e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—CD36—metabolic syndrome X	4.44e-06	2.71e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—HMGCR—metabolic syndrome X	4.43e-06	2.7e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—GOT2—metabolic syndrome X	4.43e-06	2.7e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—metabolic syndrome X	4.38e-06	2.67e-05	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism—NOS3—metabolic syndrome X	4.38e-06	2.67e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling by GPCR—AKT1—metabolic syndrome X	4.36e-06	2.66e-05	CbGpPWpGaD
Indomethacin—PPARA—Gene Expression—AKT1—metabolic syndrome X	4.36e-06	2.65e-05	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—ALB—metabolic syndrome X	4.35e-06	2.65e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—ABCA1—metabolic syndrome X	4.33e-06	2.64e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—SLC2A4—metabolic syndrome X	4.33e-06	2.64e-05	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—PPARG—metabolic syndrome X	4.3e-06	2.62e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—ABCA1—metabolic syndrome X	4.22e-06	2.57e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—SLC2A4—metabolic syndrome X	4.22e-06	2.57e-05	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—INS—metabolic syndrome X	4.22e-06	2.57e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—GOT1—metabolic syndrome X	4.19e-06	2.55e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—GGT1—metabolic syndrome X	4.19e-06	2.55e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—IRS1—metabolic syndrome X	4.18e-06	2.54e-05	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—NOS3—metabolic syndrome X	4.16e-06	2.53e-05	CbGpPWpGaD
Indomethacin—UGT1A1—Metabolism—PTGS2—metabolic syndrome X	4.15e-06	2.53e-05	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism—PTGS2—metabolic syndrome X	4.15e-06	2.53e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—PPARA—metabolic syndrome X	4.13e-06	2.52e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—GOT1—metabolic syndrome X	4.09e-06	2.49e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—GGT1—metabolic syndrome X	4.09e-06	2.49e-05	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism—PTGS2—metabolic syndrome X	4e-06	2.44e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—AGT—metabolic syndrome X	4e-06	2.44e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—INS—metabolic syndrome X	4e-06	2.44e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—metabolic syndrome X	3.99e-06	2.43e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—APOB—metabolic syndrome X	3.96e-06	2.41e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—ABCA1—metabolic syndrome X	3.95e-06	2.4e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—SLC2A4—metabolic syndrome X	3.95e-06	2.4e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—APOE—metabolic syndrome X	3.92e-06	2.39e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Metabolism—AKT1—metabolic syndrome X	3.91e-06	2.38e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—APOA1—metabolic syndrome X	3.87e-06	2.36e-05	CbGpPWpGaD
Indomethacin—ALB—Hemostasis—TGFB1—metabolic syndrome X	3.87e-06	2.36e-05	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—ALB—metabolic syndrome X	3.87e-06	2.36e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—PLA2G4A—metabolic syndrome X	3.85e-06	2.35e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—GGT1—metabolic syndrome X	3.82e-06	2.33e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—GOT1—metabolic syndrome X	3.82e-06	2.33e-05	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—PTGS2—metabolic syndrome X	3.8e-06	2.32e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—LPL—metabolic syndrome X	3.78e-06	2.31e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—TGFB1—metabolic syndrome X	3.71e-06	2.26e-05	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—NOS3—metabolic syndrome X	3.7e-06	2.25e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—SERPINE1—metabolic syndrome X	3.67e-06	2.24e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—CD36—metabolic syndrome X	3.59e-06	2.19e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—APOB—metabolic syndrome X	3.56e-06	2.17e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—IL6—metabolic syndrome X	3.54e-06	2.16e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—NOS3—metabolic syndrome X	3.51e-06	2.14e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—APOB—metabolic syndrome X	3.47e-06	2.12e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—PLA2G4A—metabolic syndrome X	3.46e-06	2.11e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—TGFB1—metabolic syndrome X	3.45e-06	2.11e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—PPARG—metabolic syndrome X	3.41e-06	2.08e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—LPL—metabolic syndrome X	3.4e-06	2.07e-05	CbGpPWpGaD
Indomethacin—PPARA—Metabolism—AKT1—metabolic syndrome X	3.39e-06	2.06e-05	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—PTGS2—metabolic syndrome X	3.38e-06	2.06e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—PLA2G4A—metabolic syndrome X	3.38e-06	2.06e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—INS—metabolic syndrome X	3.35e-06	2.04e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—PPARA—metabolic syndrome X	3.34e-06	2.04e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—LPL—metabolic syndrome X	3.31e-06	2.02e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—AKT1—metabolic syndrome X	3.27e-06	1.99e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—APOB—metabolic syndrome X	3.24e-06	1.98e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—AGT—metabolic syndrome X	3.24e-06	1.97e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—CD36—metabolic syndrome X	3.23e-06	1.97e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—APOE—metabolic syndrome X	3.17e-06	1.93e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—PLA2G4A—metabolic syndrome X	3.15e-06	1.92e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—CD36—metabolic syndrome X	3.15e-06	1.92e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—APOA1—metabolic syndrome X	3.13e-06	1.91e-05	CbGpPWpGaD
Indomethacin—PPARG—Gene Expression—AKT1—metabolic syndrome X	3.12e-06	1.9e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—LPL—metabolic syndrome X	3.1e-06	1.89e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—ALB—metabolic syndrome X	3.07e-06	1.87e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—PPARA—metabolic syndrome X	3e-06	1.83e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—CD36—metabolic syndrome X	2.94e-06	1.79e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—NOS3—metabolic syndrome X	2.94e-06	1.79e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—PPARA—metabolic syndrome X	2.93e-06	1.78e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—AGT—metabolic syndrome X	2.91e-06	1.77e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—APOE—metabolic syndrome X	2.85e-06	1.73e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—AGT—metabolic syndrome X	2.84e-06	1.73e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—APOA1—metabolic syndrome X	2.81e-06	1.71e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—IL6—metabolic syndrome X	2.79e-06	1.7e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—APOE—metabolic syndrome X	2.78e-06	1.69e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—PPARG—metabolic syndrome X	2.76e-06	1.68e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—APOA1—metabolic syndrome X	2.75e-06	1.67e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—PPARA—metabolic syndrome X	2.74e-06	1.67e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—INS—metabolic syndrome X	2.71e-06	1.65e-05	CbGpPWpGaD
Indomethacin—ALB—Hemostasis—AKT1—metabolic syndrome X	2.69e-06	1.64e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—AGT—metabolic syndrome X	2.65e-06	1.61e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—IL6—metabolic syndrome X	2.6e-06	1.59e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—APOE—metabolic syndrome X	2.6e-06	1.58e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—AKT1—metabolic syndrome X	2.58e-06	1.57e-05	CbGpPWpGaD
Indomethacin—UGT2B7—Metabolism—AKT1—metabolic syndrome X	2.57e-06	1.56e-05	CbGpPWpGaD
Indomethacin—ABCC3—Metabolism—AKT1—metabolic syndrome X	2.57e-06	1.56e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—APOA1—metabolic syndrome X	2.57e-06	1.56e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—PPARG—metabolic syndrome X	2.48e-06	1.51e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—INS—metabolic syndrome X	2.43e-06	1.48e-05	CbGpPWpGaD
Indomethacin—PPARG—Metabolism—AKT1—metabolic syndrome X	2.43e-06	1.48e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—PPARG—metabolic syndrome X	2.42e-06	1.47e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—AKT1—metabolic syndrome X	2.4e-06	1.46e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—NOS3—metabolic syndrome X	2.38e-06	1.45e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—INS—metabolic syndrome X	2.37e-06	1.45e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—TGFB1—metabolic syndrome X	2.32e-06	1.41e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—PPARG—metabolic syndrome X	2.26e-06	1.38e-05	CbGpPWpGaD
Indomethacin—SLCO1A2—Metabolism—AKT1—metabolic syndrome X	2.24e-06	1.36e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—ALB—metabolic syndrome X	2.23e-06	1.36e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—INS—metabolic syndrome X	2.22e-06	1.35e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—ALB—metabolic syndrome X	2.18e-06	1.33e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—PTGS2—metabolic syndrome X	2.17e-06	1.32e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—NOS3—metabolic syndrome X	2.13e-06	1.3e-05	CbGpPWpGaD
Indomethacin—UGT1A1—Metabolism—AKT1—metabolic syndrome X	2.09e-06	1.27e-05	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism—AKT1—metabolic syndrome X	2.09e-06	1.27e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—NOS3—metabolic syndrome X	2.08e-06	1.27e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—ALB—metabolic syndrome X	2.03e-06	1.24e-05	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism—AKT1—metabolic syndrome X	2.01e-06	1.23e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—PTGS2—metabolic syndrome X	1.95e-06	1.19e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—NOS3—metabolic syndrome X	1.94e-06	1.18e-05	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—AKT1—metabolic syndrome X	1.91e-06	1.16e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—PTGS2—metabolic syndrome X	1.9e-06	1.16e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—PTGS2—metabolic syndrome X	1.78e-06	1.08e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—IL6—metabolic syndrome X	1.75e-06	1.06e-05	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—AKT1—metabolic syndrome X	1.7e-06	1.04e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—AKT1—metabolic syndrome X	1.61e-06	9.82e-06	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—AKT1—metabolic syndrome X	1.35e-06	8.23e-06	CbGpPWpGaD
Indomethacin—ALB—Metabolism—AKT1—metabolic syndrome X	1.09e-06	6.65e-06	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—AKT1—metabolic syndrome X	9.8e-07	5.97e-06	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—AKT1—metabolic syndrome X	9.57e-07	5.83e-06	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—AKT1—metabolic syndrome X	8.94e-07	5.45e-06	CbGpPWpGaD
